Registry for patients with heart failure using pulmonary artery pressure monitors
Official title: Hemodynamic Frontiers in Heart Failure Registry
Run by University of Kansas Medical Center · NCT06425848 · Data updated 2026-11-12
This study is collecting information from patients with heart failure who have special sensors in their lungs to help improve treatment and understanding of their condition.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 100 Years |
| Sex | All |
| Enrollment | 2000 (estimated) |
| Sponsor | University of Kansas Medical Center Academic / other |
| Locations | 12 sites (La Jolla, California and 11 other locations) |
| Status | Recruiting |
| Started | October 21, 2022 |
| Main results expected | December 31, 2030 |
| Study ends | December 31, 2030 |
| Registry record updated | May 22, 2024 |
| Trial ID | NCT06425848 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults with NYHA Class III heart failure who have had prior hospitalizations or those meeting expanded FDA indications.
✕Probably not a fit
Patients under 18 years of age, pregnant women, or those unable to maintain continuity of care in a heart failure clinic may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The HF2 Registry aims to collect comprehensive data on patients with heart failure who have been implanted with pulmonary artery pressure sensors. This observational, multi-center registry will gather demographic, clinical, laboratory, and hemodynamic information to enhance understanding of ambulatory hemodynamics monitoring and heart failure therapies. Patients will be recruited from heart failure clinics and will have the option to consent to participate in the registry, which will also facilitate future research opportunities based on the collected data.
Why it matters
Potential benefit: If successful, this registry could lead to improved heart failure management and therapies through better understanding of patient data.
How similar studies have gone: Other studies utilizing similar observational approaches have shown promise in advancing heart failure management, indicating potential for success in this registry.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. All patients would have been or will be implanted per indications from FDA approval/CHAMPION trial. These would be patients with NYHA (New York Heart Association) Class III heart failure who had a prior hospitalization. 2. Patients who meet the expanded FDA indication (BNP elevation without hospitalization or NYHA class II). Exclusion Criteria: 1. Patients less than 18 years of age. 2. Pregnant women at the scheduled time of PA pressure sensor implant. 3. Patients unable or unwilling to have continuity of care in the heart failure clinic.
Where it's running
-
Scripps Health
La Jolla, California, United States Recruiting -
Indiana University
Bloomington, Indiana, United States Recruiting -
University of Kansas Medical Center
Kansas City, Kansas, United States Recruiting -
Minneapolis Heart Institute Foundation/ Allina Health
Minneapolis, Minnesota, United States Recruiting -
Saint Luke's Health System
Kansas City, Missouri, United States Recruiting -
University of North Carolina/ Rex Hospital, Inc.
Raleigh, North Carolina, United States Recruiting
Show 6 more locations
-
Providence Heart Institute
Portland, Oregon, United States Recruiting -
Prisma Health
Columbia, South Carolina, United States Recruiting -
Sanford Health
Sioux Falls, South Dakota, United States Recruiting -
Austin Heart
Austin, Texas, United States Recruiting -
Houston Methodist DeBakey Heart and Vascular Center
Houston, Texas, United States Recruiting -
Fairview Health
Maplewood, Minnesota, United States Not yet recruiting
Study contacts
- Principal investigator: Hirak Shah, MD — University of Kansas Medical Center
- Study coordinator: Kartik Munshi, MPH
- Email: kmunshi@kumc.edu
- Phone: 913-945-6445
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using Apple Watch data to predict heart failure outcomes
This study is testing if data from Apple Watches can help predict heart failure problems and the chances of needing to go back to the hospital for patients with heart failure.
-
Comparing Aortix Device to Diuretics for Acute Heart Failure
This study is testing whether the Aortix device can help people with acute heart failure who aren't responding to diuretics feel better compared to standard treatment.
-
Myocardial Energetics Across Cardiovascular Disease Spectrum Using 31P-MRS
Researchers are testing whether phosphorus-31 magnetic resonance spectroscopy (31P-MRS) can map heart energy metabolism across healthy people and patients with various heart conditions.
-
Tailored digital support to cut sedentary time in long-term cardiac rehab
In adults in a long-term cardiac rehabilitation program, this study tests whether a personalized behavioural program with digital tools can reduce daily sitting time.
-
NT-proBNP–guided heart failure screening for people 65+ in rural China
This study tests whether using NT-proBNP blood tests to guide heart failure screening in adults 65 and older in rural China can find unrecognized heart problems more effectively than symptom-based screening.
-
Voice-based detection of heart failure deterioration using Noah Labs Vox
This study tests whether a voice-analysis app can flag worsening heart failure in adults by comparing its alerts to standard weight-based monitoring.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.